These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8818119)

  • 1. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication.
    Bosch JL; Hunink MG
    Med Decis Making; 1996; 16(3):217-25. PubMed ID: 8818119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication.
    Bosch JL; Hunink MG
    Qual Life Res; 2000; 9(6):591-601. PubMed ID: 11236850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in the relationship between the standard-gamble utility measure and health-status dimensions.
    Bult JR; Bosch JL; Hunink MG
    Med Decis Making; 1996; 16(3):226-33. PubMed ID: 8818120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient utilities in fibromyalgia and the association with other outcome measures.
    Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1995 Aug; 22(8):1536-43. PubMed ID: 7473480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication.
    Bosch JL; Halpern EF; Gazelle GS
    Med Decis Making; 2002; 22(5):403-9. PubMed ID: 12365482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent claudication: symptom severity versus health values.
    de Vries SO; Kuipers WD; Hunink MG
    J Vasc Surg; 1998 Mar; 27(3):422-30. PubMed ID: 9546227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk attitudes to treatment among patients with severe intermittent claudication.
    Letterstål A; Forsberg C; Olofsson P; Wahlberg E
    J Vasc Surg; 2008 May; 47(5):988-94. PubMed ID: 18455642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between health-state utilities and the SF-12 in a general population.
    Lundberg L; Johannesson M; Isacson DG; Borgquist L
    Med Decis Making; 1999; 19(2):128-40. PubMed ID: 10231075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-tradeoff values and standard-gamble utilities assessed during telephone interviews versus face-to-face interviews.
    van Wijck EE; Bosch JL; Hunink MG
    Med Decis Making; 1998; 18(4):400-5. PubMed ID: 10372582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient utilities in ankylosing spondylitis and the association with other outcome measures.
    Bakker C; Rutten-van Mölken M; Hidding A; van Doorslaer E; Bennett K; van der Linden S
    J Rheumatol; 1994 Jul; 21(7):1298-304. PubMed ID: 7966073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease.
    Mazari FA; Carradice D; Rahman MN; Khan JA; Mockford K; Mehta T; McCollum PT; Chetter IC
    J Vasc Surg; 2010 Jul; 52(1):77-84. PubMed ID: 20471779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and chained standard gambles in the assessment of coronary heart disease prevention and treatment. Canadian Collaborative Cardiac Assessment Group.
    Lalonde L; Clarke AE; Joseph L; Grover SA
    Med Decis Making; 1999; 19(2):149-56. PubMed ID: 10231077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Quality of Life Questionnaire-6 facilitates health-related quality of life assessment in peripheral arterial disease.
    Nordanstig J; Wann-Hansson C; Karlsson J; Lundström M; Pettersson M; Morgan MB
    J Vasc Surg; 2014 Mar; 59(3):700-7. PubMed ID: 24342060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Use of Short Form-36 Domain Scores and Patient Responses for Derivation of Preference-Based SF6D Index to Calculate Quality-Adjusted Life Years in Patients with Intermittent Claudication.
    Mazari FA; Shahin Y; Khan JA; Samuel N; Carradice D; McCollum PT; Chetter IC
    Ann Vasc Surg; 2016 Jul; 34():164-70. PubMed ID: 27177712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intermittent claudication questionnaire: a patient-assessed condition-specific health outcome measure.
    Chong PF; Garratt AM; Golledge J; Greenhalgh RM; Davies AH
    J Vasc Surg; 2002 Oct; 36(4):764-71; discussion 863-4. PubMed ID: 12368737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life.
    Revicki DA; Kaplan RM
    Qual Life Res; 1993 Dec; 2(6):477-87. PubMed ID: 8161982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in a group of patients with intermittent claudication.
    Ponte E; Cattinelli S
    Angiology; 1996 Mar; 47(3):247-51. PubMed ID: 8638867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.
    Blumenschein K; Johannesson M
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):189-94. PubMed ID: 9494453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in the relationship between the time tradeoff and Short Form-36 for HIV-infected and primary care patients.
    Bult JR; Hunink MG; Tsevat J; Weinstein MC
    Med Care; 1998 Apr; 36(4):523-32. PubMed ID: 9544592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the Minimally Important Difference for the VascuQol Sumscore and Its Domains in Patients with Intermittent Claudication.
    Conijn AP; Bipat S; Reekers JA; Koelemay MJ
    Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):550-6. PubMed ID: 26837479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.